You are here: Industry Insights > Market News > Glenmark receives ANDA approval for Fenofibrate caps

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Glenmark receives ANDA approval for Fenofibrate caps

financialexpressApril 11, 2017

Tag: ANDA , Glenmark

Favorites

The product will be available in USP 67 mg, 134 mg and 200 mg

Glenmark Pharmaceuticals received final approval by US FDA for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor Micronised Capsules, 67 mg, 134 mg, and 200 mg of AbbVie.

According to IMS Health sales data for the 12 month period ending February 2017, the Tricor Micronised capsules, 67 mg, 134 mg and 200 mg market achieved annual sales of approximately $97.5 million.

Previous:Lupin receives FDA approval for generic Wellbutrin XL tabs

Next:Hikma signs settlement agreement over Jazz’s Xyrem patent litigation

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

PharmaSourcesMay 16, 2024

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Biotech NewswireMay 14, 2024

Glenmark receives ANDA approval for Fenofibrate caps | Pharmasources.com

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

Biotech NewswireMay 10, 2024

Nucleic Acid Medicines Manufacture, Round 2 call.

Glenmark receives ANDA approval for Fenofibrate caps

Related News

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

You may like